You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

About the Ellipta device

The Ellipta is a multi-dose dry powder inhaler (DPI). Four different medicines for asthma and/or COPD are available using the Ellipta device. The inhaler is packaged within a moisture-protective foil tray with a desiccant and a peelable lid.

Ellipta inhaler

How to use Ellipta inhaler video

Watch our short video on how to use the Ellipta inhaler.

Video player requires JavaScript enabled. You can download this video here:

Note: The Ellipta demonstration inhaler should be replaced once the dose counter reaches zero.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to HPRA Pharmacovigilance on their website: By reporting side effects, you can help provide more information on the safety of this medicine.

Ellipta is a registered trademark of the GlaxoSmithKline Group of Companies